Which hedge funds own RCUS? ARCUS BIOSCIENCES INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in RCUS (ARCUS BIOSCIENCES INC) in their Q2 2026 13F filings, worth $403.7m in total. The largest holder by portfolio weight is Suvretta Capital Management at 3.1% of its book. 1 manager opened a new position this quarter: Millennium Management. 3 exited: Point72 Asset Management LP, Renaissance Technologies LLC, Tudor Investment.
6tracked managers holding
1opened this quarter
3exited this quarter
Which hedge funds hold RCUS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Suvretta Capital Management | Q2 2026 | 3.1% | $147.3m | 4,776,423 | -5% | reduced |
| Woodline Partners | Q2 2026 | 0.3% | $92.7m | 3,007,798 | -20% | reduced |
| Citadel Advisors | Q2 2026 | 0.1% | $96.7m | 3,135,057 | 136% | added |
| Marshall Wace | Q2 2026 | 0.1% | $60.0m | 1,945,088 | -48% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $4.1m | 133,110 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $3.0m | 96,417 | -63% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Point72 Asset Management LP | 0.1% | $2.8m |
| Renaissance Technologies LLC | 0.2% | $9.2m |
| Tudor Investment | 0.3% | $4.7m |
How has hedge fund ownership of RCUS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $403.7m |
| Q1 2026 | 8 | $322.5m |
| Q4 2025 | 5 | $297.4m |
| Q3 2025 | 5 | $178.8m |
| Q2 2025 | 5 | $123.4m |
| Q1 2025 | 6 | $93.8m |
| Q4 2024 | 5 | $91.7m |
| Q3 2024 | 5 | $104.1m |
| Q2 2024 | 4 | $108.4m |
| Q1 2024 | 4 | $113.2m |
| Q4 2023 | 4 | $55.1m |
| Q3 2023 | 5 | $32.5m |
| Q2 2023 | 3 | $20.3m |
| Q4 2022 | 2 | $33.6m |
| Q3 2022 | 1 | $1.5m |
| Q1 2022 | 2 | $37.0m |
Counts every tracked manager that disclosed RCUS in that quarter's filing, including managers that have since stopped filing.